Omni Star Financial Group, Inc. Halozyme Therapeutics, Inc. Transaction History
Omni Star Financial Group, Inc.
- $117 Million
- Q4 2024
A detailed history of Omni Star Financial Group, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Omni Star Financial Group, Inc. holds 9,334 shares of HALO stock, worth $583,748. This represents 0.38% of its overall portfolio holdings.
Number of Shares
9,334
Previous 15,370
39.27%
Holding current value
$583,748
Previous $879,000
49.26%
% of portfolio
0.38%
Previous 0.7%
Shares
2 transactions
Others Institutions Holding HALO
# of Institutions
550Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.1 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$831 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$449 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$261 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$216 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.71B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...